Latex Agglutination Test Kits Market Size Share Growth Trends Analysis Forecast to 2032

The global latex agglutination test kits market is projected to grow from $500.2 million in 2025 to $714.7 million by 2032, with a 4.6% CAGR. North America leads with 47.61% market share, driven by CLIA-certified laboratories and strong healthcare infrastructure.

Key market highlights:

• Antigen testing dominates due to widespread use in bacterial, viral and fungal disease detection
• Blood samples represent the largest segment among sample types
• Hospital-based laboratories are the primary end users
• Recent developments include Bio-Rad's acquisition of Stilla Technologies in February 2025
• COVID-19 had a mixed impact, with increased usage for certain tests (CRP, D-Dimer) but decreased testing for other conditions

Growth drivers include:

• Rising infectious and autoimmune disease prevalence
• Adoption of point-of-care diagnostic techniques
• Diverse applications across multiple diseases
• Cost-effectiveness and rapid results (15-60 minutes)

Main constraints include emergence of newer diagnostic technologies like Nucleic Acid Amplification Tests (NAATs) which offer higher sensitivity and specificity.

Report-

Fortune Business Insights - Latex Agglutination Test Kits Market Size, Share | Forecast, 2032

https://www.fortunebusinessinsights.com/latex-agglutination-test-kits-market-107155